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Objective. Oxygen-derived free radicals have been suggested as important in degeneration after spinal cord ischemia. The
aim of this study was to investigate whether erdosteine has a protective effect against spinal cord ischemia during aortic cross
clamping.
Materials and methods. New Zealand White rabbits (n ¼ 21) were divided into three groups. In the ischemia/reperfusion
group (I/R) (n ¼ 8), the infrarenal aorta of rabbits was cross clamped for 21 min and then reperfused. In erdosteine group,
the administration of erdosteine solution (50 mg/kg) was started two days before aortic cross-clamping and rabbits (n ¼ 8)
were subjected to ischemia and reperfusion. Animals in control group (n ¼ 5) underwent a surgical procedure similar to the
other groups but the aorta was not clamped. The animals were sacrificed at 72 h and histopathological, and biochemical
analyses were carried out on the lumbar spinal cords.
Results. Erdosteine treatment was associated with improved neurological function in the postoperative period.
Histopathological examination of spinal cord tissues in erdosteine group revealed changes consistent with mild ischemic
injury, but rabbits in I/R group with paraplegia had total destruction of the motor neurons. Biochemical analyses of spinal
cord tissues, in the I/R group, revealed a significant increase in the superoxide dismutase, xanthine oxidase, adenosine
deaminase and myeloperoxidase activities, and a significant depletion in glutathione peroxidase activity when compared to
that of control rabbits. Erdosteine treatment prevented the increase of all these enzymes except adenosine deaminase.
Ischemia/reperfusion produced a significant increase in the tissue malondialdehyde levels. Ischemia/reperfusion-induced
increments in malondialdehyde content of the spinal cord were significantly prevented by erdosteine treatment.
Conclusions. The present study demonstrated that erdosteine treatment before aortic cross clamping ameliorates
neurological outcome, neuronal injury and oxidative stress in the rabbit spinal cord.
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Introduction
Spinal cord injury following thoracoabdominal aortic
surgery remains a devastating and unpredictable
complication, with a reported incidences of paraplegia
of 4–33%.1 A number of techniques have been
suggested to minimize this problem, including tem-
porary shunts or partial bypass,2 hypothermia,3
drainage of cerebrospinal fluid,4 and pharmacological
measures.5,6 Regardless of the surgical technique or
method of spinal cord protection used, a reliable
preventive measure has not been reported.7 Spinal
cord injury occurring after clamping of the thoracoab-
dominal aorta is mainly due to ischemia. However, in
some patients paraplegia develops 1–5 days later
(delayed-onset paraplegia). The cause of delayed-
onset paraplegia has been attributed to embolization
or thrombosis to anterior spinal artery, postoperative
hypotension, deleterious effects of leukocytes and
microglia, free radical production, and apoptosis.8 – 10
Previously, we have shown that the administration of
caffeic acid phenethyl ester, which exhibits antioxidant
properties, before aortic cross-clamping improved
neurological outcome and oxidative damage in a
rabbit model for spinal cord ischemia/reperfusion.11
Erdosteine, which is a thiol derivative, has been
developed as a mucolytic drug and as an enhancer of
respiratory ventilation in the treatments of patients
with chronic obstructive respiratory disease.
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Pharmacological studies have also demonstrated
erdosteine is able to scavenge free oxygen radicals.12
This study was designed to investigate the protective
efficacy of erdosteine on the neurological and histo-
pathological outcomes of spinal cord ischemia and
oxidative stress due to reperfusion injury after aortic
occlusion in rabbits.
Materials and Methods
Twenty-one New Zealand White rabbits weighing
2.4–3.2 kg (mean 2.7 kg) were used in this study.
Animal care and experiments complied with the
‘Principles of Laboratory Animal Care’ and the
‘Guide for the Care and Use of Laboratory Animals’
(NIH Publication 86–23, revised 1985) and was
approved by Inonu University, School of Medicine,
Ethical Committee on the care and use of laboratory
animals.
The animals were fasted for 12 h and operated on in
a room kept at 24 8C. They were anesthetized with
intramuscular ketamine hydrochloride with an initial
dose of 50 mg/kg and xylazine 3 mg/kg, followed by
25 mg/kg fractionally as needed during the pro-
cedure. The animals were allowed to breath room air
without mechanical ventilation. Body temperature
was maintained close to 38 8C using a thermostatically
controlled heated operation table. An intravenous
catheter (24 gauge) was placed in an ear vein, and
preoperatively cefazoline 10 mg/kg was administered
as a single dose. Maintenance fluid of 0.9% NaCl was
infused at a rate of 20 ml/h during the procedure.
Surgical technique
The animals were placed in the supine position with
the pelvis partially rotated to the right. After the
surgical preparation, the vertical incision was made
from the left costal margin directed towards the pubis.
The abdominal aorta was exposed through a retro-
peritoneal approach and mobilized from just inferior
to the left renal vein down to the aortic bifurcation.
Heparin (100 IU/kg) was administered intravenously
to control group and 5 min before aortic occlusion to
I/R and erdosteine groups. The animals undergoing
aortic occlusion were divided into two groups each
consisting of eight rabbits. In the erdosteine group,
50 mg/kg erdosteine (Erdostin, Ilsan) orally; in ische-
mia/reperfusion group (I/R), a similar volume of
sterile saline solution were administered orally. The
administration of erdosteine solution was started 2
days before aortic cross-clamping to obtain steady
blood levels and maintained to the last examination
day (day 3). The last dose of erdosteine prior to
operation was administered 2 h before the aortic
clamping, because of its time to peak plasma (1.4 h).
The erdosteine and ischemia/reperfusion groups
underwent surgical procedures as described above
and spinal cord ischemia was induced with clamping
the aorta just below the renal vein with a bulldog
clamp (FB328). A second similar clamp was placed
above the aortic bifurcation for occluding iliac collat-
eral circulation. Animals were subjected to 21 min of
cross-clamp time. At the end of occlusion time, the
clamps were removed and restoration of the blood
flow was verified visually. Animals in sham control
group ðn ¼ 5Þ underwent a surgical procedure similar
to the other groups but the aorta was not occluded.
This group of animals was used for eliciting the effects
of anesthesia and operation on results and also
determining the biochemical parameters studied in
the normal spinal cord tissue. The catheters were
removed and the incisions closed.
Evaluation of neurological status
Neurological status of animals was assessed blindly by
neurologist at 6, 12, 24, 48 and 72 h. Crede’s maneuver
was used for evacuation of the urinary bladder when
necessary. According to the loss of bladder sphincter
control, animals were assessed as: 0, urinary retention
and 1, no retention. Neurological status was scored by
assessment of hindlimb motor function deficit. A score
of 0–5 was assigned to each animal (modified Tarlov’s
score), as follows:
. Score 0, no voluntary hindlimb function;
. Score 1, movements of joints perceptible;
. Score 2, active movement but able to sit with
assistance;
. Score 3, sit without assistance;
. Score 4, weak hop;
. Score 5, normal hop.
Biochemical analyses
After the last neurological examination at 72 h post-
operation, the animals were anaesthetized with the
use of ketamine (50 mg/kg), blood samples were
collected through a cardiac puncture. For biochemical
analysis, spinal cords and serum were used in all
rabbits from each group. The distal segment of the
spinal cord was subject to histopathological analyses,
and the remaining spinal cord tissues washed two
times with cold saline solution, placed into glass
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bottles, labeled, and stored in a deep freeze (230 8C)
until processing (maximum 10 h). Tissues were hom-
ogenized in four volumes of ice-cold Tris–HCl buffer
(50 mmol, pH 7.4) using a glass Teflon homogenizer
(Tempest Virtishear, Model 278069; The Virtis Com-
pany, Gardiner, NY) after cutting of the spinal cords
into small pieces with a scissors (for 2 min at
5000 rpm). Nitric oxide (NO) and malondialdehyde
(MDA) concentrations as well as protein levels were
measured at this stage. The homogenate was then
centrifuged at 5000g for 60 min to remove debris. Clear
upper supernatant fluid was taken and glutathione
peroxidase (GSH-Px), xanthine oxidase (XO), and
adenosine deaminase (ADA) activities as well as
protein concentration was carried out in this stage.
The supernatant solution was extracted with an equal
volume of an ethanol/chloroform mixture (5/3,
volume per volume [v/v]). After centrifugation at
5000g for 30 min, the clear upper layer (the ethanol
phase) was taken and used in the superoxide
dismutase (SOD) activity and protein assays. All
preparation procedures were performed at þ4 8C.
Blood samples by cardiac puncture were drawn into
potassium ethylenediaminetetra–acetic acid (EDTA)
containing tubes. The blood samples were centrifuged
at 1000g for 10 min at 4 8C to remove plasma.
MDA determination
The MDA level was determined by a method based on
the reaction with thiobarbituric acid (TBA) at 90–
100 8C.13 In the TBA test reaction, MDA or MDA-like
substances and TBA react together for production of a
pink pigment having an absorption maximum at
532 nm. The reaction was performed at pH 2–3 at
90 8C for 15 min. The sample was mixed with 2
volumes of cold 10% (w/v) trichloroacetic acid to
precipitate protein. The precipitate was pelleted by
centrifugation and an aliquot of the supernatant was
reacted with an equal volume of 0.67% (w/v) TBA in a
boiling water bath for 10 min. After cooling, the
absorbance was read at 532 nm (Ultra spec Plus,
Pharmacia LKB Biochrom Ltd, England). The results
were expressed as micromole per liter (mmol/L) in
serum, and nmol/g protein in spinal cord tissues
according to a standard graphic, which was prepared
with serial dilutions of standard 1,1,3,3-tetramethox-
ypropane.
NO determination
As NO measurement is very difficult in biological
specimens, tissue nitrite (NO2
2) and nitrate (NO3
2)
were estimated as an index of NO production. The
method for spinal cord, nitrite and nitrate levels was
based on the Griess reaction.14 Samples were initially
deproteinized with Somogyi reagent. Total nitrite
(nitrite þ nitrate) was measured after conversion of
nitrate to nitrite by copporized cadmium granules by a
spectrophotometer at 545 nm (Ultraspec Plus, Phar-
macia LKB Biochrom Ltd, England). A standard curve
was established with a set of serial dilutions (1028–
1023 mol/L) of sodium nitrite and absorbance-con-
centration graphic was prepared. Linear regression
was done by using the peak area from nitrite standard.
The resulting equation (slope) was then used to
calculate the unknown sample concentrations. Results
were expressed as micromole per gram protein for
spinal cord tissue, and micromole per liter for serum
measurements.
SOD activity determination
Total (Cu–Zn and Mn) SOD (EC 1.15.1.1) activity was
determined according to the method of Sun et al.15 The
principle of the method is based on the inhibition of
nitroblue tetrazolium (NBT) reduction by the
xanthine–xanthine oxidase system as a superoxide
generator. Activity was assessed in the ethanol phase
of the serum and spinal cord homogenate after 1.0 ml
ethanol/chloroform mixture (5/3, v/v) was added to
the same volume of sample and centrifuged. One unit
of SOD was defined as the enzyme amount causing
50% inhibition in the NBT reduction rate. SOD activity
was also expressed as units per milliliter for serum
measurements and units per miligram spinal cord
protein for tissue measurements.
XO activity determination
Xanthine oxidase activity was measured spectropho-
tometrically by the formation of uric acid from
xanthine through the increase in absorbancy at
293 nm, according to Prajda and Weber’s method.16
A calibration curve was constructed by using 10–50
milli units/mL concentrations of standard XO sol-
utions (Sigma X-1875). One unit of activity was
defined as 1 mmol of uric acid formed per minute at
37 8C, pH 7.5, and expressed as units per milliliter in
serum and units per gram protein in spinal cord
homogenate.
ADA activity determination
Plasma and tissue ADA activities were estimated
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spectrophotometrically by the method of Giusti, which
is based on the direct measurements of the formation
of ammonia, produced when ADA acts in excess of
adenosine.17 Results were expressed as units per liter
in serum, and units per gram protein in spinal cord
tissue.
GSH-Px activity determination
Glutathione peroxidase activity was measured by the
method of Paglia et al.18 The enzymatic reaction in the
tube, which contains the following items: NADPH,
reduced glutathione (GSH), sodium azide, and gluta-
thione reductase, was initiated by addition of H2O2
and the change in absorbance at 340 nm was mon-
itored by a spectrophotometer. Activity was given as
units per gram protein in spinal cord tissue. All
samples were assayed in duplicate.
Myeloperoxidase (MPO) activity determination
Myeloperoxidase activity was determined using a 4-
aminoantipyrine/phenol solution as the substrate for
MPO-mediated oxidation by H2O2 and changes in
absorbance at 510 nm (A510) were recorded.
19 One unit
of MPO activity is defined as that which degrades
1 mmol H2O2/min at 25 8C. Data are presented as mU/
g protein. All samples were assayed in duplicate.
Protein determinations
Protein assays were made by the method of Lowry
et al.20
Histopathological examination
A histopathological evaluation was carried out in the
spinal cords and abdominal aorta. The entire spinal
column and abdominal aorta with lumbar arteries was
removed. Distal parts of the specimens were fixed in
10% buffered formalin for about 10 days before being
set in paraffin blocks for sectioning. Five-micrometer
sections were cut from paraffin-embedded blocks and
the sections were taken to slides for hematoxylin and
eosin staining (H and E). Abdominal aorta and its
branches were examined for revealing possible
thrombosis or embolic occlusion.
Statistical analysis
Non-parametric analyses with Mann–Whitney U-test
were performed on the data of the physiological and
biochemical variables. Motor deficit scores of animals
were compared using repeated measures analysis of
variance (ANOVA) with the statistical significance of
each comparison adjusted for the multiple compari-
sons using a Bonferroni correction. Fisher exact
probability test was used in the analysis of bladder
and bowel function. Correlations among the biochemi-
cal parameters in each groups were tested for with
Spearman’s test. A value of P , 0:05 was considered
significant. Data are expressed as mean ^ SD. All
statistical analyses were carried out using SPSS
statistical software (SPSS 10.0 for Windows).
Results
Physiological variables and neurological outcome
Statistical analysis between the three groups for the
various physiologic variables (mean levels of blood
glucose, arterial blood gases, pH, body temperatures)
did not disclose differences. Also, there was no
difference in the loss of bladder sphincter control
between the three groups. All rabbits survived with-
out major complications. Twenty-one minutes of
ischemia resulted in severe motor deficit in the hind
limbs of all animals, while all control animals main-
tained normal motor behavior (score of 5), as assessed
by the motor deficit score (Fig. 1). Pretreatment with
erdosteine did not prevent the development of
paraplegia. Most of animals in erdosteine group
exhibited score 3 or score 4 motor function at 72 h.
The scores in erdosteine group were significantly
higher than the I/R group at 72 h (3.12 ^ 0.83 versus
1.75 ^ 1.28; P ¼ 0:01).
Fig. 1. Motor deficit score in the ischemia reperfusion,
erdosteine and control groups during 72-hour follow-up
period. The scores in erdosteine group were different from
control group at 72 h (3.12 ^ 0.83 versus 1.75 ^ 1.28;
P ¼ 0:01).
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Histopathology
Histopathological photographs of sections are shown
in Fig. 2. At 72 h, histopathologic analysis of the H and
E-stained sections from the fourth lumbosacral seg-
ments of the erdosteine, and I/R groups revealed
changes consistent with ischemic injury. The control
rabbits showed no signs of neuronal damage, with
many large motor neurons in anterior horn. In
contrast, animals in I/R group with complete paralysis
(score 0) had total destruction of the motor neurons
with intensely eosinophilic cytoplasm, Nissl granule
loss, and pronounced vacuolization of the anterior
horn, as well as by the presence of infiltrating
neutrophils and mononuclear phagocytes. In erdos-
teine group, spinal cords of rabbits scored 3–4
exhibited mild degrees of destruction such as the
perikaryon becoming shrunken. Histologic examin-
ation of abdominal aorta and its branches were
normal, and reveal no thrombus formation in all
animals.
The biochemical analysis of oxidant stress markers in spinal
cord tissue
In the I/R group, ischemia/reperfusion produced a
significant increase in the SOD, XO, ADA and MPO
activities in spinal cord tissue when compared with
control group (Table 1). Erdosteine treatment pre-
vented the increase of all those enzymes activities
produced by ischemia/reperfusion except ADA
activities. The mean SOD, XO and MPO activities in
the erdosteine group were to be 0.23 ^ 0.12 U/mg
protein ðP ¼ 0:0001Þ; 0.33 ^ 0.02 U/g protein ðP ¼
0:0001Þ; and 2.50 ^ 0.53 mU/g protein ðP ¼ 0:0001Þ;
respectively. ADA activity was increased from the
control value of 0.45 ^ 0.02 to 0.83 ^ 0.07 U/g protein
in erdosteine group.
A significant decrease in GSH-Px activities in the
I/R group was observed when compared to that of
control rabbits (0.51 ^ 0.04 versus 0.62 ^ 0.09 U/g
protein, P ¼ 0:003). Erdosteine treatment significantly
prevented the decreases in the tissue GSH-Px activities
produced by ischemia/reperfusion. The tissue GSH-
Px activities increased to 0.58 ^ 0.02 U/g protein in
erdosteine group ðP ¼ 0:01Þ:
Ischemia/reperfusion produced a significant
increase in the spinal cord tissue MDA content
(22.21 ^ 0.88 nmol/g protein), an index for lipid
peroxidation, when compared with control groups
(15.81 ^ 0.97 nmol/g protein), ðP ¼ 0:0001Þ: Ische-
mia/reperfusion-induced increments in MDA content
of the spinal cord were significantly prevented by
erdosteine treatment. The tissue MDA content in this
group remained 14.59 ^ 2.22 nmol/g protein ðP ¼
0:0001Þ:
A significant increase in spinal cord NO level was
seen in ischemia/reperfusion group when compared
to that of control rabbits (1.23 ^ 0.45 versus
0.20 ^ 0.06 mmol/g protein, P ¼ 0:001). Although it
was not statistically significant, erdosteine treatment
prevented the increases in the spinal cord tissue NO
contents produced by ischemia/reperfusion. The
spinal cord tissue NO contents were decreased to
1.05 ^ 0.54 mmol/g protein in erdosteine group.
The biochemical analyses of oxidant stress markers in serum
Ischemia/reperfusion produced a significant increase
in the XO, and ADA activities in serum when
compared with control group (Table 2). Erdosteine
treatment significantly prevented the increase of all
those enzymes activities produced by ischemia/
reperfusion. A significant decrease in ADA activities
in the I/R group was observed when compared with
control rabbits (17.24 ^ 1.58 versus 9.75 ^ 0.47 U/L,
P ¼ 0:0001). Erdosteine treatment significantly pre-
vented the decreases in the serum ADA activities
produced by ischemia/reperfusion. The serum ADA
activities were increased to 11.25 ^ 0.82 U/L in erdos-
teine group ðP ¼ 0:0001Þ:
Serum MDA levels (0.28 ^ 0.02 mmol/L) were
Table 1. Spinal cord oxidant and antioxidant status in erdosteine, ischemia/reperfusion and control groups in rabbits. Results are
expressed as mean 6 standard deviation
MDA
(nmol/g protein)
NO
(mmol/g protein)
SOD
(U/mg protein)
XO
(U/g protein)
ADA
(U/g protein)
MPO
(mU/g protein)
GSH-Px
(U/g protein)
C 15.81 ^ 0.97 0.20 ^ 0.06 0.14 ^ 0.003 0.18 ^ 0.04 0.45 ^ 0.02 2.40 ^ 0.54 0.623 ^ 0.09
I/R 22.21 ^ 0.88 1.23 ^ 0.45 0.43 ^ 0.03 0.77 ^ 0.31 0.74 ^ 0.01 4.38 ^ 0.51 0.514 ^ 0.04
E 14.59 ^ 2.22 1.05 ^ 0.54 0.23 ^ 0.12 0.33 ^ 0.02 0.83 ^ 0.07 2.50 ^ 0.53 0.589 ^ 0.02
P values
C-I/R 0.0001 0.001 0.0001 0.0001 0.0001 0.0001 0.003
C-E n.s. 0.003 n.s. n.s. 0.0001 n.s n.s
I/R-E 0.0001 n.s 0.0001 0.0001 0.001 0.0001 0.01
n.s, not significant; C, control; I/R, ischemia/reperfusion; E, erdosteine þ ischemia/reperfusion.
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increased in I/R group when compared with control
groups (0.20 ^ 0.01 mmol/L), ðP ¼ 0:0001Þ: Ische-
mia/reperfusion-induced increments in MDA content
were significantly prevented by erdosteine treatment.
The serum MDA content in this group was
0.23 ^ 0.01 mmol/L ðP ¼ 0:0001Þ: Serum NO level in
ischemia/reperfusion group was not different from
controls.
Discussion
The present study demonstrates a considerable neu-
ropotective effect of erdosteine, a potent free radical
scavanger, on neurological, biochemical and histo-
pathological status during periods of spinal cord
ischemia/reperfusion in rabbits. Erdosteine is a thiol
derivate containing two blocked sulfhydryl groups in
the aliphatic side chain which become free only after
hepatic metabolisation. The presence of two sulfhy-
dryl groups in metabolites of erdosteine, accounts for
free radical scavenging and antioxidant activity.12
Experimental and clinical studies have demonstrated
the free radical scavenging properties of erdosteine.
Free radicals and reactive oxygen species (ROS)
have been associated with the etiology and/or
progression of a number of diseases and in aging.
Oxidative stress is an imbalance wherein formation of
ROS overwhelms endogenous antioxidant defenses
and repair capacity. Under normal conditions
endogenous antioxidants including vitamins C and E
and the antioxidant enzymes SOD, CAT, and GSH-Px
have the capacity to scavenge the levels of ROS
products. In ischemic conditions, these defense mech-
anisms fail to protect tissue from oxidative damage
because of overproduction of oxygen radicals, inacti-
vation of antioxidant enzymes, and consumption of
antioxidants in the ischemic tissue.21 Indeed, a
decreased activity of mitochondrial SOD, GSH-Px
and glutathione reductase was observed in isolated
striatal mitochondria from rats subjected to ischemia
and 24 h of recirculation.22 During the thoracic aorta
operation, maintenance of a blood supply with
removing the aortic clamp supports excess generation
of oxygen free radicals in spinal cord neurons, causing
lipid peroxidation in cell membranes and oxidative
damage to DNA and proteins. The destructive activity
of free oxygen radicals on spinal cord tissue has been
Fig. 2. (a) Normal motor neuron in the anterior horn of the
gray matter. (b) Erdosteine treated-animals exhibited mini-
mal evidence of cellular damage. (c) Samples of I/R group
with paraplegia showed total destruction of the motor
neurons with intensely eosinophilic cytoplasm, Nissl gran-
ule loss, and pronounced vacuolization of the anterior horn,
as well as by the presence of infiltrating neutrophils and
mononuclear phagocytes.
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also thought as one of the causes of delayed-onset
paraplegia after the thoracoabdominal surgery.8 – 10
Therefore, a prime goal of neuroprotection is to reduce
oxidative damage in order to salvage the spinal cord
from oxidative damage.
Mitochondria are the primary source of cellular
ATP. This ATP is generated via an ATP synthase
that utilizes an inner mitochondrial membrane pH
gradient as the driving force. The free hydronium
ions (H3O
þ) are used to generate the pH gradient
and the free electrons are passed down a series of
enzyme complexes (I–IV), known as the electron
transport chain (ETC), terminating at the final
electron acceptor, which is molecular oxygen. This
reduction of molecular oxygen forms superoxide
(O2
2) ions that can react with Hþ to form hydrogen
peroxide (H2O2) and hydroxyl radicals (OH
2).23
Therefore, a side effect of ATP generation from
mitochondria is the formation of ROS, which, under
physiological conditions, are ‘detoxified’ by antiox-
idant systems. Mitochondria, as well as representing
a source of free radicals in ischemia, are also at risk
of injury from ROS with peroxidation of membrane
lipids a possible key component in mitochondrial
dysfunction.24 On the other hand, the degradation
of ATP after reperfusion by huge amount of
molecular oxygen, ROS can be generated by XO.
In our study, XO and ADA activities were found to
be elevated in I/R group when compared to
controls showing increased purine catabolism.
After erdosteine administration XO elevation was
prevented.
Oxygen derived free radicals are believed to play an
important role in spinal cord injury post aortic surgery.
It is reasonable to suppose that the level of the
postischemic tissue pO2 tension may play a critical
role in a massive formation of free oxygen radicals. In
our study, all animals of the erdosteine and I/R groups
experienced severe hind limb motor deficit. This
means that a strategy focusing only on the attenuation
of the ischemia/reperfusion injury alone (i.e. antiox-
idant agents) is not likely to prevent severe spinal cord
damage. In addition spinal cord hypoperfusion needs
to be avoided during thoracoabdominal aortic surgery.
Our study indicates that erdosteine significantly
prevented the depletion of GSH-Px activities in spinal
cord tissue by scavenging the free radicals produced
by I/R. Also, erdosteine significantly prevented the
increase of NO and MDA concentrations in the tissue
of rabbit. In the present study, lipid peroxidation was
monitored by measuring of MDA which results from
free radical damage to membrane components of the
cells. We observed a significant increase in the MDA
concentration in the spinal cord tissue of rabbits in I/R
group. Erdosteine significantly attenuated the increase
of MDA concentration in the tissue. This is probably
due to its elimination capacity for free oxygen radicals.
The protection of spinal cord from IR injury by
erdosteine may also due to the reduction of lipid
peroxidation of neurons in spinal cord. Also, pre-
ventive effect of erdosteine in the depletion of GSH-Px
activities may be due to its free radical scavenging and
antioxidant activity. Our study indicated the marked
elevation in NO level in the I/R group and erdosteine
significantly attenuated this increment.
MPO is an enzyme located in leukocytes. Tissue
MPO levels may suggest leukocyte infiltration into
spinal cord tissue after I/R. According to our findings,
MPO elevated in the tissue of I/R group and erdostein
treatment prevented this elevation protecting spinal
cord. Consistently, we also observed the presence of
infiltrating neutrophils and mononuclear phagocytes
in the spinal cord tissues of I/R group.
In conclusion, we consider that erdosteine may
prevent I/R-caused oxidative damage after thoracoab-
dominal aortic surgery. Further studies are warranted
to define the optimal dosage of this drug.
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